The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Translational Molecular Hematology

Davidsson group

Our research

Whereas clinical hematology is the branch of medicine concerned with the study, diagnosis, treatment, and prevention of blood disorders, molecular hematology can be defined as the study of hematopoiesis from a molecular and genetic perspective. For several decades, the hematopoietic system has been the foremost biological model when investigating human malignant disease. Seminal findings in both the laboratory and clinical setting have resulted in a staggering increase of survival in pediatric leukemia, as well as a plethora of new therapeutic tools, making hematology a model of modern translational research.



The main goal of our laboratory is to use the current understanding of hematopoiesis and put this in a clinical context, to be able to employ this knowledge in identifying new biomarkers and potential therapeutic targets for primarily pediatric blood disorders. In addition, another goal is to take novel clinical discoveries, e.g. mutations or epigenetic findings linked to specific hematopoietic pathophenotypes, and use them as a foundation for basic research projects regarding hematopoietic stem and progenitor cell regulation and function.



List of Team Davidsson's publications


(name linked to profile in Lund University research portal)

Josef Davidsson

Principal Investigator, Josef [dot] Davidsson [at] med [dot] lu [dot] se



Josef Davidsson

Principal Investigator
PhD, MD.
Division of Molecular Hematology
Department of Laboratory Medicine
Lund Stem Cell Center
BMC B12, Lund University
221 84 Lund, Sweden

Phone: + 46 46 222 03 13
Mail:Josef [dot] Davidsson [at] med [dot] lu [dot] se

Profile in Lund University research portal